1 / 6

Day 2

d. Wound at Day 0. Wound at Day 2. a. Supplementary Figure S1. c. En face image of the wound. b. *. 100 80 60 40 20 0. Adjacent crypts. Wound. Adjacent crypts. % wound re-epithelialization. *. Transverse image of H&E staining of the wound bed. HBSS LGG. Biopsy Injury.

blaze
Download Presentation

Day 2

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. d Wound at Day 0 Wound at Day 2 a Supplementary Figure S1 c En face image of the wound b * 100 80 60 40 20 0 Adjacent crypts Wound Adjacent crypts % wound re-epithelialization * Transverseimage of H&E staining of the wound bed HBSS LGG Biopsy Injury Wound monitoring by endoscope & Intrarectal adminstration of LGG or HBSS d D0 D1 D2 D3 D4 D5 D6 Day 1 Day 2 Day 4 Day 6 Wild type, HBSS Day 4 Day 6 Day 2 Day 1 Wild type, LGG

  2. Supplementary Figure S2 a Media 50 500 5,000 LGG (2.5107 cfu/ml) LGG (2.5107cfu/ml) fMLF (500nM) fMLF: (nM) 5106 1.25108 2.5107 Media LGG : (cfu/ml) To-pro 3 (DNA) ROS (CM-H2DCF-DA) ROS (CM-H2DCF-DA) 15’ 30’ 60’ 5’ b wound wound wound wound HBSS wound wound wound wound LGG

  3. Supplementary Figure S2 (continued) c 2.5 x 108 cfu 2.5 x 109 cfu 2.5 x 1010 cfu Control 2.5 x 107 cfu wound wound wound wound wound wound WT wound wound wound wound wound FPR1 KO 50 nM 500 nM 5 uM 50 uM Control d wound wound wound wound wound WT wound wound wound wound wound FPR1 KO

  4. WT, LGG Supplementary Figure S3 a Min 0 10 15 20 P-FAK 125 kDa P-paxillin 68 kDa Actin 45 kDa b Adjacent crypts Adjacent crypts Staining for EdU chase assay to detect cellular migration Day 0 1 2 4 Biopsy wound & labeling of cells by EdU Wound Wound bed Fpr1-/- Wild type c HBSS, 1hr D * * HBSS 6hr % migration LGG 6hr WT HBSS WT LGG Fpr1 -/- HBSS Fpr1 -/- LGG EdU (chase 6 hrs) DNA

  5. Supplementary Figure S4 LGG a 0 10 15 20 Min P-ERK 44/42 kDa Actin 45 kDa b Actin P-ERK WT, NAC + LGG Fpr1-/-, LGG Nox1-/-IEC, LGG WT, LGG WT, HBSS 15 min 60 min

  6. a Supplementary Figure S5 I.P. injection of EdU 2hr prior to wound bed collection & EdU staining to detect proliferation Biopsy injury Day 0 Day 1 Day2 Day4 B EdU DNA Wild Type, Day 1 Wild Type, Day 2 Wild Type, Day 4 Adjacent crypts Adjacent crypts Adjacent crypts Wound Wound Wound b Wild Type, LGG, Day 2 Wild Type, HBSS, Day 2 Adjacent crypts Adjacent crypts Adjacent crypts Adjacent crypts Wound Wound EdU DNA c Fpr1-/-, LGG Nox1-/-IEC , LGG Wild type, HBSS Wild type, LGG Wound Wound Wound Wound DNA Ki67 (+)

More Related